News

The randomized, double-blind, placebo-controlled, single-center, single ascending dose study will evaluate the safety and pharmacokinetic profile of SPL-017. A total of 74 healthy adult male subjects will be

The randomized, multi-center, placebo-controlled, dose-ranging study is designed to evaluate the safety, tolerability and efficacy of RX-10045 in improving the signs and symptoms of dry eye. Approximately 200

Under the terms of the development and licensing agreement ConvaTec receives exclusive global marketing and distribution rights for the Engenex negative pressure wound therapy (NPWT) system. In addition,

The Phase I single-center, multiple ascending dose study tested the safety, tolerance and pharmacodynamics of AR9281 in 24 healthy male and female volunteers. Participants were enrolled in three

The formal adoption of the positive opinion follows the Committee for Medicinal Products for Human Use recommendation previously announced in November 2008. The marketing authorization is likely to

The Committee for Medicinal Products for Human Use (CHMP) positive opinion is now referred for final action to the European Commission, which grants approval in the EU. The

The current good manufacturing practice (cGMP) lab will conduct testing for clinical programs spanning all phases of drug development. The cGMP lab will be licensed by the Irish

Under the terms of the transaction, Wyeth has acquired Thiakis for approximately $30 million. Additional payments of up to approximately $120 million would be payable upon the achievement

The FDA decision is based on a recent Canadian study evaluating 4,709 adults and 1,905 children who were treated with intravenous (IV) acetylcysteine for acetaminophen overdose. Data from